Strong Balance Sheet Stocks

Results

3578

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

3578 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	RADA	US$9.87	-2.4%	5.0%	US$490.9m	US$14.00	85.0	83.7%	n/a	Capital Goods
	FFHL	US$8.30	0.7%	8.1%	US$27.1m	n/a	2.8	n/a	n/a	Materials
	PBIP	US$15.13	-0.7%	9.6%	US$117.7m	US$15.00	1.0	87.9%	1.9%	Banks
	BKFG	US$94.00	0%	n/a	US$54.8m	n/a	6.8	n/a	n/a	Diversified Financials
	TARA	US$4.07	7.7%	36.6%	US$214.1m	US$26.57	1.3	50.5%	n/a	Pharmaceuticals & Biotech
	VNDA	US$5.96	-1.2%	31.6%	US$344.6m	US$14.13	1.6	62.4%	n/a	Pharmaceuticals & Biotech
	BLBD	US$73.35	6.8%	75.3%	US$2.3b	US$81.71	17.5	14.9%	n/a	Capital Goods
	SGMT	US$6.53	0.5%	-7.2%	US$389.0m	US$26.20	3.9	16.2%	n/a	Pharmaceuticals & Biotech
	EBMT	US$22.84	-2.4%	47.2%	US$182.6m	US$23.50	0.9	4.6%	2.5%	Banks
	CZWI	US$21.25	4.2%	60.4%	US$204.2m	US$24.00	1.1	20.3%	2.0%	Banks
	GHRS	US$21.70	6.6%	83.3%	US$1.4b	US$39.50	5.7	3.9%	n/a	Pharmaceuticals & Biotech
	BRNS	US$0.70	0.7%	-19.7%	US$28.6m	US$5.50	0.4	n/a	n/a	Pharmaceuticals & Biotech
	III	US$4.16	-3.0%	-12.2%	US$197.1m	US$6.67	18.8	17.6%	4.3%	Software
	FMBH	US$45.55	-1.3%	29.1%	US$1.2b	US$49.00	1.1	17.2%	2.2%	Banks
	ELMA	US$24.85	0%	17.2%	US$28.6m	n/a	0.7	n/a	2.4%	Banks
	NRIX	US$17.12	11.9%	47.3%	US$1.8b	US$31.00	24.7	17.3%	n/a	Pharmaceuticals & Biotech
	FBSI	US$32.90	0%	26.0%	US$79.3m	n/a	1.2	n/a	1.5%	Banks
	ATRC	US$27.12	-1.4%	-14.2%	US$1.4b	US$47.00	2.5	51.0%	n/a	Healthcare
	OAKC	US$38.10	-7.1%	21.3%	US$192.5m	n/a	1.3	n/a	1.2%	Banks
	SEPN	US$35.80	17.5%	241.3%	US$1.6b	US$45.78	22.3	-32.4%	n/a	Pharmaceuticals & Biotech
	NNNN	US$15.86	-3.5%	37.2%	US$708.4m	n/a	108.7	n/a	n/a	Pharmaceuticals & Biotech
	SNT	US$2.30	-7.1%	-44.0%	US$56.2m	n/a	39.3	n/a	n/a	Tech
	GORA.F	US$0.017	4.6%	61.4%	US$2.6m	n/a	11.9	n/a	n/a	Materials
	MSBC	US$103.00	0.5%	15.0%	US$302.0m	n/a	1.3	n/a	n/a	Banks

Page 1 of 100